Current approaches to vaccination against human immunodeficiency viruses.
Gluckman
J C
JC
Laboratoire de Biologie et Génétique des Déficits Immunitaires, Cervi, Hôpital Pitié-Salpétrière, Paris, France.
Yagello
M
M
Bahraoui
E
E
Girard
M
M
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D000939:Epitopes / Q000276:immunology; D015686:Gene Products, env / Q000276:immunology; D015693:Gene Products, nef / Q000276:immunology; D015483:HIV Antibodies / Q000096:biosynthesis / Q000276:immunology; D019302:HIV Envelope Protein gp160; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D008251:Macaca / Q000276:immunology; D002679:Pan troglodytes / Q000276:immunology; D011498:Protein Precursors / Q000276:immunology; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines; D054311:nef Gene Products, Human Immunodeficiency Virus
D000939:Epitopes; D015686:Gene Products, env; D015693:Gene Products, nef; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D054311:nef Gene Products, Human Immunodeficiency Virus